Hyung Chun
Adjunct Professor at Stanford University School of Medicine
New Haven, Connecticut
Overview
Work Experience
Partner
2021 - Current
Foresite Capital is a healthcare and life sciences investment firm.
Adjunct Professor
2023
Adjunct Associate Professor
2022
Associate Professor of Medicine and Pathology with Tenure
2019 - 2022
Co-Director, Yale Cardiovascular Research Center
2021 - 2021
Associate Professor of Medicine
2015 - 2019
Assistant Professor
2009 - 2015
Board Member
2022
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.
Raised $150,000,000.00 from Corner Ventures, 5AM Ventures, Westlake Village BioPartners and Foresite Capital.
Board Observer
2021
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Raised $487,000,000.00 from Fidelity, T. Rowe Price, HBM Healthcare Investments, Global BioAccess Fund, Foresite Capital, The Healthcare Innovation Investment, General Catalyst, Woodline Partners, Ascenta Capital and BlackMars Capital.
Chief Cardiology Fellow
2008 - 2009
Cardiology Fellow
2004 - 2009
Internal Medicine Resident
2002 - 2004
HHMI/NIH Research Scholar
1999 - 2001
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Raised $5,000,000.00 from National Institute of Allergy and Infectious Diseases.